CentralReach Acquires Behavior Science Technology Inc. the Leading, Research-Backed Treatment Fidelity Platform for Applied Behavior Analysis that Has Demonstrated Ability to Help Increase Behavior Technician Tenure by 500%.
17 Septiembre 2024 - 2:00PM
CentralReach, the leading provider of Autism and IDD Care software
for ABA, multidisciplinary, and special education, today announced
the acquisition of Behavior Science Technology Inc. (BST), a
research-backed treatment fidelity platform designed to collect,
measure, and track treatment fidelity for Applied Behavior Analysis
(ABA) therapy in a standardized way. This strategic acquisition
marks a significant milestone in CentralReach's mission to provide
the most complete AI-powered care management platform that arms
each member of the care team with the tools they need to improve
treatment fidelity, RBT retention, supervision effectiveness, and
caregiver engagement, while enhancing the quality and consistency
of care provided to individuals with autism. Once integrated,
Care360 alongside CentralReach’s EMR will offer ABA providers a
path towards measurement-based care that can be brought to payers
to support their approach towards care.
Co-founders, Tricia Glick, BCBA and Troy Glick along with
Abigail Blackman, PhD, BCBA-D will be joining CentralReach to
continue to lead the evolution of BSTperform and its integration
into the Care360 platform.
“I’m thrilled to welcome Tricia, Troy, and Abby to the
CentralReach team,” said Chris Sullens, CEO of CentralReach.
“Recognizing the importance and potential of a treatment fidelity
tool like BST’s, CentralReach made a significant early investment
in BST in 2022 to support its growth. Since then, we’ve followed
their journey closely while they proved product market fit and
validated the material impact treatment fidelity has on clinical
quality, outcomes, and retention in the ABA industry. We are
excited to bring BST’s innovative approach to an even broader
audience. With BST's established success in developing a
research-backed platform for treatment fidelity, we believe that
joining forces with CentralReach and tightly integrating their IP
into our Care360 platform will allow us to leverage AI across our
four billion+ clinical data points. This collaboration will enable
us to scale these innovations to even more providers, enhancing
care and outcomes on a much larger scale.”
Addressing a Critical Need in Applied Behavior Analysis Care
Delivery
The current clinical process for ABA care involves a complex
cycle of skill gap assessment, individualized care plan creation,
care delivery, data collection and analytics, and plan adjustments,
all aimed at improving client outcomes. However, during the care
delivery phase, a crucial component—supervision—has traditionally
lacked a standardized method for measurement and tracking to ensure
that Registered Behavior Technicians (RBTs) consistently adhere to
prescribed care plans, ultimately impacting the effectiveness of
treatment or treatment fidelity.
BST has developed the industry’s first tech-enabled,
research-based platform to address this issue. By providing a
standardized approach to collect, measure, and track treatment
fidelity, BST offers unprecedented transparency into the care
delivery process, empowering clinicians to continuously improve the
quality of care.
The Acquistion Provides a Path Towards Stronger RBT Retention
and Measurement-Based Care
The integration of BST’s platform into Care360 brings several
key advantages:
- Standardization of Care: The combination of BST’s
innovative platform with CentralReach’s existing CR Care360
platform will standardize how care is delivered, providing a clear
framework for evaluating and improving care delivery across the
board. This will lead to more consistent and effective outcomes for
individuals receiving applied behavior analysis care.
- Enhanced RBT Retention: By offering a standardized
approach to measuring treatment fidelity, BST’s platform supports
RBTs in delivering high-quality care, which research showed led to
increased job satisfaction and clinical competency, resulting in a
500% increase in RBT retention. This aligns with CentralReach’s
Care360 platform’s focus on supporting the professional development
and retention of RBTs, a critical factor in the overall success of
care delivery.
- Pioneering Measurement-Based Care: The acquisition paves
the way for the adoption of measurement-based, or value-based, care
within the autism and IDD care industry. The aggregation between
BSTperform and CentralReach’s clinical solutions offer providers
both a standardized approach and a way to aggregate all critical
data providing them with the quantitative evidence needed to
demonstrate improved outcomes—a vital component of value-based care
models.
“Partnering with CentralReach, the undisputed leader in Autism
and IDD care software, was a natural choice for us at BST,” shared
Tricia Glick. “CentralReach recognized the potential of our vision
and supported us through their investment. We’ve been committed to
advancing the field of ABA through our innovative, research-based
solutions, and we believe that integrating BSTperform into
CentralReach’s comprehensive platform will help further expand our
impact. Together, we can accelerate the adoption of
standardized treatment fidelity measures and drive meaningful
improvements in care delivery and outcomes across the
industry."
This latest acquisition is the second that CentralReach made in
2024 and 14th overall as the company continues to expand its
offerings to support the future of Autism and IDD care.
To learn more about how BSTperform can improve treatment
fidelity, go to https://www.behaviorsciencetech.com/.
To learn more about how CR Care360 can support more
connected care, go to
https://centralreach.com/solutions/care360.
About CentralReach
CentralReach is the leading provider of autism and IDD care
software, providing the only complete, end-to-end software and
services platform that helps children and adults diagnosed with
autism spectrum disorder (ASD) and related intellectual and
developmental disabilities (IDD) - and those who serve them -
unlock potential, achieve better outcomes, and live more
independent lives. With its roots in Applied Behavior Analysis, the
company is revolutionizing how the lifelong journey of autism and
IDD care is enabled at home, school, and work with powerful and
intuitive solutions purpose-built for each care setting.
Trusted by more than 175,000 professionals globally,
CentralReach is committed to ongoing product advancement,
market-leading industry expertise, world-class client satisfaction,
and support of the autism and IDD community to propel autism and
IDD care into a new era of excellence. For more
information, please visit CentralReach.com or follow us
on LinkedIn and Facebook.
CentralReach
pr@centralreach.com